Table 2 Comparison of Group 1 and Group II patients
From: Sacroiliitis in children and adolescents with familial Mediterranean fever
Findings | Group I (n = 63) | Group II (n = 102) | P value |
|---|---|---|---|
Gender (Female/Male), n (%) | 25/38 (39.7)/ (60.3) | 12/90 (11.8)/ (88.2) | < 0.001 |
Enthesitis, n (%) | 28 (44.4) | 36 (35.2) | 0.18 |
Heel pain, n (%) | 23 (36.5) | 42 (41.1) | 0.62 |
Low back pain, n (%) | 11 (17.4) | 48 (47.0) | < 0.001 |
Ankylosis, n (%) | 0 (0) | 5 (4.9) | 0.07 |
Positivity of HLA-B27, n (%) | 4 (6.3) | 51 (50) | < 0.001 |
Leukocyte count, (× 103/mm3) | 9800 (7200–12,000) | 9720 (6800–11,800) | 0.33 |
CRPa (mg/L) (normal range:0–5) | 14.4 (0.8–142) | 4.6 (0.1–137) | < 0.001 |
ESRa(mm/hour) (normal range:0–20) | 32 (20–120) | 16 (1–112) | < 0.001 |
Methotrexate, n (%) | 19 (30.1) | 24 (23.5) | 0.22 |
Salazopyrin, n (%) | 46 (73.1) | 87 (85.2) | 0.06 |
Biologic drugs, n (%) | 21 (33.3) | 32 (31.3) | 0.79 |